In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
Can you apply?
This grant is for academic medical centers, research institutions, and independent researchers seeking to develop and validate high-resolution imaging technologies for visualizing inner ear structures and pathology. Applicants must have access to appropriate laboratory and clinical facilities, relevant preliminary data, and appropriate institutional review and approval mechanisms. This is an NIH R01 grant mechanism supporting early-stage to established investigators conducting clinical trial optional research. Eligible applicants include universities, medical schools, hospitals, and independent research institutions. Awards support innovative research with potential clinical applications in otology and hearing sciences. The scope is broad but focused on imaging methodologies that advance our ability to visualize inner ear anatomy and disease in living subjects, with clinical translation pathways encouraged.
Program description
This funding opportunity aims to support the development of in vivo high-resolution structural and functional imaging technologies for the living human inner ear. Proposed projects should focus on improving the resolution of current imaging techniques or developing new imaging techniques that can visualize inner ear structures in vivo with significantly greater detail and accuracy than currently possible. Both structural and functional aspects, including visualizing dynamic elements are important to development of new and improved techniques. Projects may also focus on developing new imaging probes or contrast agents that can enhance visualization of the inner ear structures. Ultimately, research supported in response to this RFA is to encourage technologies that allow, for example, structures such as hair cells, otoliths, membranes, ions, and vasculature to be viewed in detail in awake patients in a clinical setting using non-invasive techniques. To achieve this goal, a multi-disciplinary team approach that takes advantage of the expertise of each team member is highly encouraged. Studies in humans and intermediate studies in animals, but not non-mammalian species, may be proposed to develop or advance the needed technology. Any intermediate studies must articulate a clear path of the proposed methodology to application in awake humans or define the limitations and the usefulness in anesthetized humans.
Who can apply
Eligible applicants
How to apply
Application links
Required documents
- SF-424 (R&R) Application for Federal Assistance (NIH Form)
- Project Narrative (12-15 pages typically, plus figures and references per NIH format guidelines)
- Detailed Budget (Form R&R Budget with justification narrative)
- Biographical Sketches (of all key personnel, typically 2-3 pages each)
- Supporting Documentation (Letters of Support/Intent from collaborators, institutional endorsements)
- Data Management and Sharing Plan
- Vertebrate Animal section (if applicable) with IACUC approval or status
- Human Subjects section (if applicable) with IRB approval or status, risk assessment, and inclusion/exclusion strategies
- Resource Sharing Plan (for unique materials/technology)
- Conflict of Interest Disclosure
- Institutional endorsement/approval routing form
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.173 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$67,501,043
-
$41,811,330
-
$29,666,573
-
$25,009,162
-
$22,883,624
-
$22,740,456
-
$16,596,227
-
$13,255,879
-
$12,363,350
-
$12,276,804
Top States by Funding
- MA 11 awards $142.6M
- CA 10 awards $101.6M
- IA 5 awards $77.5M
- CT 2 awards $76.3M
- MD 7 awards $56.9M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.173). How funding has trended year over year.
| 2024 | $422,034,489 | |
| 2025 | $422,700,014 | |
| 2026 est. | $427,030,000 |
FAQ
Who can apply for this R01 grant?
Eligible organizations include universities, medical schools, hospitals, independent research institutions, and nonprofit organizations with 501(c)(3) status. Individual investigators at these institutions can serve as Principal Investigators. International organizations may apply through U.S. institutional affiliations. Some restrictions apply to for-profit entities.
What is the application deadline and timeline?
The current deadline is October 1, 2026, with applications opening January 6, 2025. R01 grants typically have multiple annual deadlines; check NIH Grants.gov for additional submission dates. Plan 3-6 months of preparation time for a competitive application.
What types of research activities are supported?
This grant supports development of high-resolution imaging technologies for inner ear visualization, including technological innovation, validation studies, and research with optional clinical trial components. Both preclinical and clinical research pathways are eligible depending on your preliminary data and institutional capacity.
How competitive is this grant, and what is the typical funding range?
R01 grants are moderately to highly competitive, typically funded in the $200,000-$500,000 per year range depending on project scope and budget justification. Success rates for NIH R01s are typically 15-25%; strong preliminary data and innovation are essential.
What are common reasons applications get rejected?
Lack of adequate preliminary data, insufficient technical innovation, unclear clinical relevance, inadequate budget justification, weak project design, and missing or incomplete supporting materials (biosketches, letters of support) are frequent reasons for rejection or scoring problems.
💡 Tips for applicants
- Develop compelling preliminary data showing proof-of-concept for your imaging approach. Reviewers expect evidence that your technology works before investing R01 funding. Even small pilot studies or ex vivo validation data strengthen applications significantly.
- Clearly articulate the unmet clinical need your imaging technology addresses. Explain how current imaging modalities fall short and how your approach will enable better diagnosis, monitoring, or treatment of inner ear disease. Connect innovation to clinical impact.
- Assemble a multidisciplinary team with expertise in imaging physics/engineering, otology, and clinical validation. Demonstrate complementary skills through biosketches and letters of support. Include collaborators with access to patient populations if your research requires human subjects.
- Budget realistically for equipment, personnel, and validation studies. NIH reviewers scrutinize budgets carefully on R01s. Justify high-cost items (imaging equipment, microscopy, etc.) and explain how they directly support your aims. Include costing for regulatory pathways (FDA) if applicable.
- Address feasibility and timeline explicitly. Show that your team can realistically complete the proposed work, secure necessary approvals (IRB, IACUC), access relevant specimens or patient populations, and deliver measurable outcomes within the 3-5 year project period.
⚠️ Common mistakes
Applications often fail due to insufficient preliminary data or lack of technical proof-of-concept, leaving reviewers uncertain whether the proposed imaging approach is genuinely novel or feasible. Another common issue is weak or absent clinical framing—reviewers want to understand not just the technology, but how it addresses real diagnostic or therapeutic needs in inner ear disease. Finally, many applicants underestimate the rigor required for R01s: incomplete team biosketches, vague project timelines, unrealistic budgets without justification, and missing institutional support letters significantly harm competitiveness.
Similar grants
- OPEN Strengthening U.S. Market Mastery and Investment Ties (SUMMIT) — U.S. Mission to Jordan
- OPEN Rural Community Health Integration2026 — New York State Department of Health
- OPEN FY26 Bureau of Land Management Rangeland Resource Management – Bureau wide — Bureau of Land Management
- OPEN FY26 Bureau of Land Management Cultural and Paleontological Resource Management – Bureau wide — Bureau of Land Management
- OPEN FY26 Bureau of Land Management Youth Conservation Corps – Bureau wide — Bureau of Land Management